Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 09/15/16 | 8-K | Current report filing |
|
4 | |
| 09/07/16 | 8-K | Current report filing |
|
32 | |
| 09/07/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/23/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/18/16 | 8-K | Current report filing |
|
4 | |
| 08/16/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/11/16 | 8-K | Current report filing |
|
33 | |
| 08/11/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
49 |
| 08/01/16 | DEF 14A | Definitive proxy statements |
|
24 | |
| 07/20/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
